PNC-27 (10mg)

$169.00

PNC-27 (10mg) is a research-grade peptide primarily studied for its potential role in cancer research, specifically in tumor suppression and cell apoptosis (programmed cell death). PNC-27 is derived from a tumor-suppressing protein and has shown promise in studies related to targeting cancer cells for destruction, particularly in solid tumors. It works by binding to cell membranes of cancer cells, inducing cellular apoptosis while sparing healthy cells, making it a promising candidate in the study of selective cancer therapies. With 99% purity, PNC-27 (10mg) is ideal for preclinical research on cancer biology, tumor targeting, and apoptotic pathways.

SKU: YPB.275 Category:
Description

Key Features:

  • PNC-27 (10mg) is a synthetic peptide studied for its potential to induce apoptosis in cancer cells and suppress tumor growth, particularly in solid tumors.
  • 99% Purity: Manufactured with 99% purity, PNC-27 (10mg) is a high-quality peptide for scientific research into cancer treatment, tumor targeting, and cell death mechanisms.
  • Targeted Cancer Therapy: PNC-27 is designed to bind specifically to the cell membranes of cancer cells, triggering apoptosis while leaving healthy cells unaffected.
  • Apoptosis and Tumor Suppression: PNC-27 promotes cellular apoptosis through its interaction with cellular membranes, making it a valuable tool in cancer cell death research.
  • Cancer and Tumor Research: Studies show that PNC-27 could potentially be used as part of targeted cancer therapies to reduce tumor growth in a selective and non-toxic manner.

Common Research Applications:

  • Tumor Suppression and Apoptosis Induction: PNC-27 (10mg) is mainly studied for its ability to induce cell death in cancer cells, especially solid tumors, by binding to cancer cell membranes and promoting apoptosis.
  • Cancer Cell Targeting: PNC-27 has shown selectivity for cancerous cells, targeting and destroying tumor cells while leaving normal, healthy cells largely unaffected, making it a promising candidate for targeted cancer therapies.
  • Preclinical Cancer Therapy Studies: PNC-27 is frequently used in preclinical studies to explore new cancer treatments that utilize apoptotic pathways to selectively kill tumor cells while minimizing damage to surrounding healthy tissues.
  • Mechanisms of Tumor Growth Inhibition: Research on PNC-27 is focused on understanding how the peptide’s interaction with cell membranes can inhibit tumor growth by promoting the natural death of cancer cells.
  • Selective Cancer Treatment Research: PNC-27 is a potential therapeutic agent in research aimed at developing less toxic, highly targeted cancer treatments, offering a more precise approach to treating solid tumors and other cancer types.
Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “PNC-27 (10mg)”

Your email address will not be published. Required fields are marked *

Disclaimer
Research Use Only – Not for Human Consumption!

All BioSynth Peptides products are intended for laboratory research purposes only. They are not for human consumption, not for medical or veterinary use, and not approved by the FDA or any regulatory authority. By proceeding, you confirm you are a qualified researcher or institution handling regulated laboratory materials in compliance with applicable laws.
COA